As of the latest SEC filings, MoonLake Immunotherapeutics (MLTX) is held by 33 institutional funds. The largest fund shareholder is T. Rowe Price Health Sciences Fund, Inc. (PRHSX), holding an estimated $16,534,220.56 in market value, representing 0.15% of its portfolio.
Funds holding MoonLake Immunotherapeutics (MLTX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MLTX
- CIK:
- 0001821586
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.15% | $16,534,220.56 | 887,029 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.05% | $2,513,700.58 | 143,558 | Feb 28, 2026 | Apr 24, 2026 |
|
-
JNL Multi-Manager Small Cap Value Fund
|
ETF | Independent / Boutique | 0.12% | $2,040,092.08 | 109,447 | Mar 31, 2026 | May 28, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.01% | $1,676,127.24 | 95,724 | Feb 28, 2026 | Apr 28, 2026 |
|
ESML
iShares ESG Aware MSCI USA Small-Cap ETF
|
ETF | BlackRock / iShares | 0.06% | $1,506,385.30 | 86,030 | Feb 28, 2026 | Apr 23, 2026 |
|
DLHAX
Nomura Healthcare Fund
|
MF | Independent / Boutique | 0.22% | $1,491,200.00 | 80,000 | Mar 31, 2026 | May 28, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 0.80% | $1,105,633.93 | 63,143 | Feb 28, 2026 | Apr 29, 2026 |
|
USCAX
Victory Small Cap Stock Fund
|
MF | Independent / Boutique | 0.11% | $977,853.24 | 59,698 | Apr 30, 2026 | Jun 25, 2026 |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
ETF | Invesco | 0.79% | $951,530.58 | 58,091 | Apr 30, 2026 | Jun 26, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $733,283.78 | 41,878 | Feb 28, 2026 | Apr 24, 2026 |
|
ONEQ
Fidelity Nasdaq Composite Index ETF
|
ETF | Fidelity | 0.01% | $566,063.28 | 32,328 | Feb 28, 2026 | Apr 24, 2026 |
|
NUSC
Nuveen ESG Small-Cap ETF
|
ETF | Independent / Boutique | 0.04% | $551,563.74 | 33,673 | Apr 30, 2026 | Jun 24, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.05% | $523,877.20 | 28,105 | Mar 31, 2026 | May 28, 2026 |
|
OPTZ
Optimize Strategy Index ETF
|
ETF | Independent / Boutique | 0.22% | $455,170.16 | 24,419 | Mar 31, 2026 | Jun 1, 2026 |
|
JAFMX
Health Sciences Trust
|
MF | John Hancock | 0.18% | $398,616.40 | 21,385 | Mar 31, 2026 | May 29, 2026 |
|
BBC
Virtus Biotech Clinical Trials Etf
|
ETF | Independent / Boutique | 0.82% | $305,667.18 | 18,661 | Apr 30, 2026 | Jun 22, 2026 |
|
-
EQ/T.Rowe Price Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.19% | $304,782.64 | 16,351 | Mar 31, 2026 | May 26, 2026 |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
ETF | Fidelity | 0.01% | $238,623.84 | 14,568 | Apr 30, 2026 | Jun 23, 2026 |
|
TMED
T. Rowe Price Health Care ETF
|
ETF | T. Rowe Price | 0.89% | $181,162.16 | 9,719 | Mar 31, 2026 | May 28, 2026 |
|
MRSPX
BlackRock Advantage SMID Cap Fund, Inc.
|
MF | BlackRock / iShares | 0.02% | $127,423.04 | 6,836 | Mar 31, 2026 | May 26, 2026 |
|
ESGV
VANGUARD ESG U.S. STOCK ETF
|
ETF | Vanguard | 0.00% | $126,299.63 | 7,213 | Feb 28, 2026 | Apr 28, 2026 |
|
USMIX
Victory Extended Market Index Fund
|
MF | Independent / Boutique | 0.01% | $117,985.14 | 7,203 | Apr 30, 2026 | Jun 25, 2026 |
|
BME
BlackRock Health Sciences Trust
|
CEF | BlackRock / iShares | 0.02% | $110,125.12 | 5,908 | Mar 31, 2026 | May 28, 2026 |
|
-
Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.02% | $73,926.24 | 3,966 | Mar 31, 2026 | May 27, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | $70,832.00 | 3,800 | Mar 31, 2026 | May 27, 2026 |
Advertisement (320x50)